NCT05626101 2024-02-13
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
Al-Azhar University
Phase NA Unknown
Clinical Trials
10 trialsNCT06211881 2024-01-18
Chi-GVM Regimen for the Treatment of R/R PTCL
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT02627807 2020-06-16
Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase NA Unknown
NCT04432402 2020-06-16
Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT02716961 2016-03-24
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase NA Unknown
NCT02685228 2016-02-18
SLOWDOSE001
The First Hospital of Jilin University
Phase NA Unknown
NCT01411072 2014-10-03
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
AHS Cancer Control Alberta
Phase NA Unknown
NCT00079365 2013-12-04
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
National Cancer Institute (NCI)
Phase NA Unknown
NCT01201044 2010-09-14
DO201001
Third Military Medical University
Phase NA Unknown
NCT01125020 2010-05-18
Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation
Shanghai Jiao Tong University School of Medicine
Phase NA Unknown